Firebrick opens a new US retail route for Nasodine

Nasodine moves from online sales towards US pharmacies

Firebrick Pharma Limited (ASX:FRE) is putting its commercial emphasis behind a more ambitious US distribution strategy, moving Nasodine products beyond online channels and into the retail pharmacy market. The decision followed the company’s attendance at the National Association of Chain Drug Stores trade expo in Boston and what Firebrick described as strong online sales growth.

The company has appointed US-based non-executive director Al Moghaddam as US Commercial Director to lead the retail marketing effort. Firebrick says he has experience managing distribution through chains including CVS and Walgreens, as well as pharmaceutical wholesalers McKesson, Cardinal Health and Amerisource. The move builds on the phased US pharmacy push, which earlier involved interest from up to six regional pharmacy groups representing about 700 stores, although no binding orders were disclosed in that earlier update.

New sinus rinse expands the product range

Firebrick also launched Nasodine Sinus Rinse on 21 October, adding a third product to its upper-respiratory portfolio alongside Nasodine Nasal Spray and Nasodine Throat Spray. The company says it continued production work on the new product during the quarter, but the filing provides no sales forecast or launch targets for the rinse.

The quarter included a A$293,000 R&D Tax Incentive payment tied to A$673,000 of eligible research and development spending in fiscal 2026 on new Nasodine products. That payment was previously linked to the company’s expanding product pipeline and is now reflected directly in quarterly cash flow.

Cash falls to A$875,000 as retail expansion begins

Firebrick used A$398,000 in operating cash during the September quarter, compared with A$729,000 in cash operating expenses. The difference largely reflects the R&D payment, while operating expenses were A$110,000 lower than in the June quarter, chiefly because research and development spending fell by A$98,000.

Cash at quarter-end was A$875,000, down from A$1.322 million three months earlier. The company reported no financing facilities and recorded A$49,000 of financing transaction costs. On the Appendix 4C calculation, the existing cash balance represents an estimated 2.2 quarters of funding at the reported operating cash-use rate. That is a snapshot rather than a forecast: the estimate could change as retail marketing, production and sales activity develops.

Sales growth meets a tighter funding window

Sales receipts fell by A$39,000 from the June quarter, which Firebrick attributed to seasonal factors, while saying annualised sales continued to grow, particularly in the US. Related-party payments totalled A$285,000, comprising executive salaries and non-executive director fees.

The tension in the update is clear. Firebrick is adding products and pursuing a potentially larger US sales channel, but it is doing so with less than three quarters of funding on the company’s own current-rate measure and without reported debt facilities. The next quarterly report should show whether retail distribution converts the US interest into receipts quickly enough to extend that runway.